Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Change in Accured Expenses (2020 - 2025)

Core Scientific's Change in Accured Expenses history spans 6 years, with the latest figure at -$42.3 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 190.56% year-over-year to -$42.3 million; the TTM value through Dec 2025 reached -$17.4 million, down 1025.53%, while the annual FY2025 figure was -$17.4 million, 1025.53% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$42.3 million at Core Scientific, down from $34.7 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $117.4 million in Q4 2023 and bottomed at -$42.3 million in Q4 2025.
  • The 5-year median for Change in Accured Expenses is $3.3 million (2021), against an average of $9.4 million.
  • The largest annual shift saw Change in Accured Expenses soared 9563650.0% in 2021 before it crashed 1042.49% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $38.3 million in 2021, then crashed by 54.33% to $17.5 million in 2022, then surged by 571.9% to $117.4 million in 2023, then plummeted by 60.17% to $46.8 million in 2024, then crashed by 190.56% to -$42.3 million in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Change in Accured Expenses are -$42.3 million (Q4 2025), $34.7 million (Q3 2025), and -$12.5 million (Q2 2025).